Results for telopeptide translation from Dutch to English

n-telopeptide
n-telopeptide

c-telopeptide verhoogd
c-telopeptide increased

n-telopeptide urine normaal
n-telopeptide urine normal

collageen cross-linked n-telopeptide urine
collagen cross-linked n-telopeptide urine

collageen cross-linked n-telopeptide urine abnormaal
collagen cross-linked n-telopeptide urine abnormal

c-telopeptide en botvormingmarkers: osteocalcine, procollageen type 1 n-terminaal propeptide en botspecifieke alkalinefosfatase).
in the osteoporosis treatment trials, fablyn therapy resulted in consistent, statistically significant suppression of bone resorption and bone formation, as reflected by changes in serum and urine markers of bone turnover (e. g., c-telopeptide and markers of bone formation: osteocalcin, procollagen type 1 n-terminal propeptide, and bone-specific alkaline phosphatase).

urineconcentraties van botresorptiemarker ctx (c-terminaal telopeptide vrijgekomen uit type i collageen) waren significant afgenomen in de ibandroninezuurgroep in vergelijking met placebo.
urinary concentrations of the bone resorption marker ctx (c- terminal telopeptide released from type i collagen) were significantly reduced in the ibandronic acid group compared to placebo.

de urineconcentraties van botresorptiemarker ctx (c-terminaal telopeptide vrijgekomen uit type i collageen) waren significant afgenomen in de ibandroninezuur groep in vergelijking met placebo.
(c-terminal telopeptide released from type i collagen) were significantly reduced in the ibandronic acid group compared to placebo.

verlagingen in pth werden in verband gebracht met niet-significante verlagingen van merkers van botmetabolisme (botspecifieke alkalische fosfatase, n-telopeptide, bot turnover en botfibrose).
reductions in pth were associated with non-significant reductions of bone metabolism markers (bone specific alkaline phosphatase, n-telopeptide, bone turnover and bone fibrosis).